Zacks Rating on DaVita healthCare Partners Inc. - OTC Outlook PDF Print

As much as 10 analysts have advised buy on DaVita healthCare Partners Inc. (NYSE:DVA) with an average broker rating of 1.8. Experts at Zacks have given it a short term rating of 2, which means that the investors can Buy for the short term positions.

DaVita healthCare Partners Inc. (NYSE:DVA) should head towards $89 per share according to 6 Analysts in consensus. However, if the road gets shaky, the stock may fall short to $83 per share. The higher price estimate target is at $96 according to the Analysts. Currently the company Insiders own 0.2% of DaVita HealthCare Partners Inc. Company shares. In the past six months, there is a change of -58.01% in the total insider ownership. Institutional Investors own 86.6% of Company shares. During last 3 month period, 0% of total institutional ownership has changed in the company shares. DaVita healthCare Partners Inc. (NYSE:DVA) : On Monday heightened volatility was witnessed in DaVita healthCare Partners Inc. (NYSE:DVA) which led to swings in the share price. The shares opened for trading at $78.53 and hit $80.11 on the upside , eventually ending the session at $79.55, with a gain of 0.77% or 0.61 points. The heightened volatility saw the trading volume jump to 2,077,168 shares. The 52-week high of the share price is $85.17 and the company has a market cap of $17,099 million. The 52-week low of the share price is at $70.41 . The company shares have rallied 7.72% from its 1 Year high price. On Apr 27, 2015, the shares registered one year high at $85.17 and the one year low was seen on Jul 31, 2014. The 50-Day Moving Average price is $82.07 and the 200 Day Moving Average price is recorded at $79.11. DaVita HealthCare Partners Inc., formerly DaVita Inc., is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2011, the Company provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. It also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. In July 2013, DaVita, a division of DaVita HealthCare Partners Inc announced the acquisition of the dialysis operations of Malaysias Caring Dialysis Centre Group (CDC Group) by DVA (Malaysia) Sdn Bhd.

...

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.